Document:

Exhibit 10.1

 

Execution Version

 

BOARD REPRESENTATION AGREEMENT

 

THIS BOARD REPRESENTATION
AGREEMENT, dated as of August 1, 2019 (this “Agreement”), is entered into by and between Archrock, Inc.,
a Delaware corporation (the “Company”), and JDH Capital Holdings, L.P., a Texas limited partnership (“JDH”).
The Company and JDH are herein referred to as the “Parties.” Capitalized terms used but not defined herein shall
have the meaning assigned to such terms in that certain Asset Purchase Agreement, dated as of June 23, 2019, by and between Archrock
Services, L.P., a Delaware limited partnership and a wholly owned subsidiary of the Company (“ASLP”), the Company
and Elite Compression Services, LLC, a Delaware limited liability company (“Elite”) (the “Purchase
Agreement”).

 

Recitals

 

WHEREAS, JDH is an
Affiliate of Elite;

 

WHEREAS, this Agreement
is entered into in connection with the transactions contemplated by the Purchase Agreement, pursuant to which ASLP agreed to purchase
from Elite, and Elite agreed to sell to ASLP, substantially all of the assets of Elite, in exchange for (i) an amount of cash equal
to $205,000,000 and (ii) 21,656,683 newly issued shares of common stock, par value $0.01 per share (“Company Common Stock”),
of the Company, issued to JDH;

 

WHEREAS, pursuant to
Section 6.16 of the Purchase Agreement, the Company agreed to take such action prior to Closing as is necessary to (i) increase
the number of positions on the board of directors of the Company (the “Board”) by one and (ii) cause an individual
designated by Elite and satisfying the independence standards under the rules of the New York Stock Exchange and reasonably acceptable
to the Company (any such individual, including, for the avoidance of doubt, the Initial Seller Designee (as defined below) or any
Replacement Designee (as defined below), a “Seller Designee”) to be appointed to the Board until the next annual
meeting of stockholders of the Company, in each case effective as of the Closing Date; and

 

WHEREAS, to induce
the parties thereto to enter into the transactions contemplated by the Purchase Agreement, each of the Parties is required to deliver
this Agreement, duly executed by each of the Parties, contemporaneously with the closing of the transactions contemplated by the
Purchase Agreement.

 

NOW, THEREFORE, in
consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged by each of the Parties hereto, the Parties hereby agree as follows:

 

Agreement

 

Section 1.               
Director Designation Rights.

 

(a)              
General. Beginning on the date of this Agreement and ending on the Designation Right Termination Date (as
defined below), the Company shall include a Seller Designee meeting the requirements set forth in Section 2 on the slate
of nominees for election to the Board at each annual meeting of stockholders of the Company (and shall recommend in the proxy statement
to be distributed in connection with the applicable annual meeting that stockholders vote in favor of such Seller Designee’s
election) for so long as JDH continues to satisfy the Minimum Holding Threshold (as defined below). For purposes of this Agreement,
the “Designation Right Termination Date” shall be the date on which JDH or its successors (together with all
Affiliates of such Person) ceases to hold on an aggregate basis at least 7.5% of the then-issued and outstanding shares of Company
Common Stock (the “Minimum Holding Threshold”). The initial Seller Designee designated pursuant to this Section
1(a) as of the Closing Date (and who shall be appointed by the Company to the Board as of the Closing Date) is Jeffery D. Hildebrand
(the “Initial Seller Designee”), subject to and conditioned upon the Initial Seller Designee’s execution
of a Confidentiality and Non-Disclosure Agreement in the form attached hereto as Annex A (the “Confidentiality
Agreement”), dated as of the Closing Date. JDH may elect, at its sole discretion, to designate a new individual to serve
as the Seller Designee at any time by written notice to the Company; provided, that such Person has executed the Confidentiality
Agreement.

 

     

     

    

 

(b)              
Removal of Designee. Directors of the Company are subject to removal pursuant to the applicable provisions
of the organizational documents of the Company; provided, however, for as long as this Agreement remains in effect,
subject to applicable law, the Seller Designee or any Replacement Designee may only be removed or required to resign with the consent
of JDH. JDH may remove or cause the Seller Designee to resign from the Board at any time, with or without cause.

 

(c)              
Vacancies; Replacement Designee. Prior to the Designation Right Termination Date, any vacancy created by the death,
resignation or removal of the Seller Designee shall, upon receipt of written instructions from JDH (or such successors or Affiliates
holding the Minimum Holding Threshold) identifying a replacement designee who satisfies the requirements of a Seller Designee
set forth in Section 2 (the “Replacement Designee”), be filled by the Board pursuant to such instructions
within three business days of receipt of such instructions. Prior to the Designation Right Termination Date, such Replacement
Designee shall serve until the Company’s next ensuing annual meeting of stockholders and, at such meeting and each subsequent
annual meeting of stockholders of the Company, shall be included on the slate of nominees for election to the Board and recommended
by the Board in accordance with the terms of this Agreement. The resignation by any Seller Designee shall not be effective until
JDH shall have designated a Replacement Designee pursuant to this Section 1(c). For the avoidance of doubt, any Seller
Designee that ceases to be a member of the Board (whether by removal, retirement or otherwise) can only be replaced by JDH pursuant
to the terms of this Agreement; provided, however, that if JDH fails to designate a Replacement Designee within
30 days of any vacancy of the Seller Designee, the Company may appoint an interim successor director until JDH makes such designation.

 

(d)              
D&O Insurance. At all times Seller Designees and Replacement Designees (i) while serving as a member of
the Board, shall be entitled to coverage under any “directors’ and officers’” liability insurance maintained
by the Company (or any Person on behalf of the Company) and (ii) shall be entitled to all other rights to indemnification, advancement
of expenses and exculpation, in each case, as are then made available to any other present or former member of the Board (in such
capacity). For clarity, no adverse amendment to such rights will be effective as to a Seller Designee or Replacement Designee on
a go forward basis without such Seller Designee or Replacement Designee’s written consent.

 

    2

     

    

 

(e)              
Business Opportunities. Without limiting the effect of this Agreement or the Purchase Agreement, from and
after the the date hereof, to the fullest extent permitted by applicable law, the Company, on behalf of itself and its Subsidiaries
(including ASLP), renounces any interest or expectancy of the Company and its Subsidiaries in, or in being offered an opportunity
to participate in, any business opportunities that are from time to time presented to JDH or any of its Affiliates (whether present
or future) or any of their respective Representatives, Affiliates or Subsidiaries, including any director (including, for the avoidance
of doubt, any Seller Designee or Replacement Designee) of the Company who is also an Affiliate or Subsidiary of JDH or a Representative
of such an Affiliate or Subsidiary of JDH (each, a “Specified Party”), even if the business opportunity is one
that the Company or its Subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if granted
the opportunity to do so, and no Specified Party shall have any duty to communicate or offer any such business opportunity to the
Company or be liable to the Company or any of its Subsidiaries or any equityholder, including for breach of any fiduciary or other
duty, as a director, or equityholder or otherwise, unless, in the case of a Person who is a director (including, for the avoidance
of doubt, any Seller Designee or Replacement Designee) of the Company, such business opportunity is offered to such director in
his or her capacity as a director of the Company. The Company has taken and agrees to take such action (including through the Board)
as is necessary to give full effect to the renunciation contemplated by this Section 1(e).

 

(f)              
Termination of Designation Rights. Upon the Designation Right Termination Date, the right of JDH (or such successors
or Affiliates holding the Minimum Holding Threshold) to designate a Seller Designee shall terminate and, if requested in writing
by the Board, the Seller Designee then serving on the Board, promptly shall resign as a member of the Board. If the Seller Designee
does not resign upon such request, then a majority of the other directors then serving on the Board may remove the Seller Designee
as a member of the Board.

 

(g)              
Conflicts of Interest; Recusal; No Compensation. Notwithstanding any rights to be granted or provided to a
Seller Designee hereunder, the Board may exclude the Seller Designee from access to any Board or Committee materials or information
or meeting or portion thereof or written consent if the Board determines, in good faith (after reasonable consultation with the
Seller Designee regarding the reasons therefor), that including the Seller Designee in discussions relating to such determination
or providing the Seller Designee with such access would reasonably be expected to result in a conflict of interest with the Company;
provided, that (i) such exclusion shall be limited to the portion of the Board or Committee material or information and/or
meeting or written consent that is the basis for such exclusion and shall not extend to any portion of the Board or Committee material
and/or meeting that does not involve or pertain to such exclusion and (ii) the Seller Designee shall be given reasonable prior
written notice of such exclusion (or, if prior notice is not practicable, as promptly as practical thereafter). The matters set
forth on Annex B hereto shall be deemed to involve a conflict of interest with the Company (it being understood that Annex
B has been provided for illustrative purposes and, for the avoidance of doubt, the exclusion of a matter from Annex B
shall not be deemed an indication or determination that such matter does not involve a conflict of interest). Subject to the foregoing
provisions of this clause (g), a Seller Designee shall receive the same information provided to other members of the Board, at
the same time as such information is provided to other members of the Board and including monthly information packages, shall be
provided with reasonable access to management and shall be entitled to receive customary reimbursement of fees and expenses incurred
in connection with his or her service as a member of the Board and/or any Committee thereof consistent with the Company’s
policies applicable to the other members of the Board. A Seller Designee shall not be entitled to compensation from the Company,
including compensation paid to other directors of the Company in the ordinary course.

 

    3

     

    

 

Section 2.               
Director Qualifications. Any Seller Designee shall be required to
have the following qualifications, as determined in the reasonable judgment of a majority of the other members of the Board: (a)
such Seller Designee shall be required to have the requisite skill and experience to serve as a director of a public company and
(b) such Seller Designee shall not have been prohibited from serving as a director pursuant to any rule or regulation of the Securities
and Exchange Commission or any national securities exchange on which shares of the Company Common Stock are listed or admitted
to trading. JDH agrees (x) upon the Company’s request to timely provide the Company with accurate and complete information
relating to any Seller Designee as may be required to be disclosed by the Company under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or the Securities Act of 1933, as amended (the “Securities Act”),
and the rules and regulations promulgated thereunder and (y) to cause such Seller Designee to comply with the Section 16 obligations
under the Exchange Act. Any Seller Designee shall be required to agree to and be bound by any policies or procedures of the Board
that are applicable to other non-employee directors, including, for the avoidance of doubt, the Company’s insider trading
policy, corporate governance guidelines and code of business conduct.

 

Section 3.               
Miscellaneous.

 

(a)              
Entire Agreement. This Agreement is intended by the Parties as a final expression of their agreement and intended
to be a complete and exclusive statement of the agreement and understanding of the Parties hereto in respect of the subject matter
contained herein. There are no restrictions, promises, warranties or undertakings other than those set forth or referred to herein
with respect to the rights granted by the Company, JDH, the Seller Designee or any of their respective Affiliates. This Agreement
supersedes all prior agreements and understandings between the Parties with respect to the subject matter hereof.

 

(b)              
Notices. All notices and demands provided for in this Agreement shall be in writing and shall be given as
provided in the Purchase Agreement.

 

(c)              
Interpretation. Section references in this Agreement are references to the corresponding Section to this Agreement,
unless otherwise specified. All references to instruments, documents, contracts and agreements are references to such instruments,
documents, contracts and agreements as the same may be amended, supplemented and otherwise modified from time to time, unless otherwise
specified. The word “including” shall mean “including but not limited to” and shall not be construed to
limit any general statement that it follows to the specific or similar items or matters immediately following it. Whenever any
determination, consent or approval is to be made or given by a Party, such action shall be in such Party’s sole discretion,
unless otherwise specified in this Agreement. If any provision in this Agreement is held to be illegal, invalid, not binding or
unenforceable, (i) such provision shall be fully severable and this Agreement shall be construed and enforced as if such illegal,
invalid, not binding or unenforceable provision had never comprised a part of this Agreement, and the remaining provisions shall
remain in full force and effect and (ii) the Parties hereto shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated
hereby are consummated as originally contemplated to the greatest extent possible. When calculating the period of time before which,
within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference
date in calculating such period shall be excluded, and if the last day of such period is a non-Business Day, the period in question
shall end on the next succeeding Business Day. Any words imparting the singular number only shall include the plural and vice versa.
The words such as “herein,” “hereinafter,” “hereof” and “hereunder” refer to this
Agreement as a whole and not merely to a subdivision in which such words appear unless the context otherwise requires. The division
of this Agreement into Sections and other subdivisions and the insertion of headings are for convenience of reference only and
shall not affect or be utilized in construing or interpreting this Agreement.

 

    4

     

    

 

(d)              
Governing Law; Submission to Jurisdiction. This Agreement, and all claims or causes of action (whether in
contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance
of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty
made in or in connection with this Agreement), will be construed in accordance with and governed by the Laws of the State of Delaware
without regard to principles of conflicts of Laws. Any action against any Party relating to the foregoing shall be brought in any
federal or state court of competent jurisdiction located within the State of Delaware, and the Parties hereto hereby irrevocably
submit to the non-exclusive jurisdiction of any federal or state court located within the State of Delaware over any such action.
Each of the Parties hereby irrevocably waives, to the fullest extent permitted by applicable Law, any objection that it may now
or hereafter have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum for the
maintenance of such dispute. Each of the Parties hereto agrees that a judgment in any such dispute may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by Law.

 

(e)              
Waiver of Jury Trial. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY WAIVES, AND AGREES TO CAUSE ITS AFFILIATES
TO WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (i) ARISING
UNDER THIS AGREEMENT OR (ii) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT
OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER
IN CONTRACT, TORT, EQUITY OR OTHERWISE. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND,
ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL
COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF
THEIR RIGHT TO TRIAL BY JURY.

 

(f)               
No Waiver; Modifications in Writing.

 

(i)                
Delay. No failure or delay on the part of any Party in exercising any right, power or remedy hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or
further exercise thereof or the exercise of any other right, power or remedy. The remedies provided for herein are cumulative and
are not exclusive of any remedies that may be available to a Party at law or in equity or otherwise.

 

(ii)             
Specific Waiver. Except as otherwise provided herein, no amendment, waiver, consent, modification or termination
of any provision of this Agreement shall be effective unless signed by each of the Parties hereto affected by such amendment, waiver,
consent, modification or termination. Any amendment, supplement or modification of or to any provision of this Agreement, any waiver
of any provision of this Agreement and any consent to any departure by a Party from the terms of any provision of this Agreement
shall be effective only in the specific instance and for the specific purpose for which made or given. Except where notice is specifically
required by this Agreement, no notice to or demand on a Party in any case shall entitle such Party to any other or further notice
or demand in similar or other circumstances. Any investigation by or on behalf of any Party shall not be deemed to constitute a
waiver by the Party taking such action of compliance with any representation, warranty, covenant or agreement contained herein.

 

    5

     

    

 

(g)              
Execution in Counterparts. This Agreement may be executed in any number of counterparts and by different Parties
hereto in separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original
and all of which counterparts, taken together, shall constitute one and the same agreement. The exchange of copies of this Agreement
and of signature pages by facsimile or electronic transmission constitutes effective execution and delivery of this Agreement as
to the Parties and may be used in lieu of the original Agreement. Signatures of the Parties transmitted by facsimile or electronic
transmission will be deemed to be their original signatures for any purpose whatsoever.

 

(h)              
Binding Effect; Assignment. This Agreement will be binding upon and inure to the benefit of the Parties hereto
and their respective successors and permitted assigns, but will not be assignable or delegable by any Party hereto without the
prior written consent of each of the other Parties.

 

(i)                
Independent Counsel. Each of the Parties acknowledges that it has been represented by independent counsel
of its choice throughout all negotiations that have preceded the execution of this Agreement and that it has executed the same
with consent and upon the advice of said independent counsel. Each Party and its counsel cooperated in the drafting and preparation
of this Agreement and the documents referred to herein, and any and all drafts relating thereto will be deemed the work product
of the Parties and may not be construed against any Party by reason of its preparation. Accordingly, any rule of Law or any legal
decision that would require interpretation of any ambiguities in this Agreement against the Party that drafted it is of no application
and is hereby expressly waived.

 

(j)                
Specific Enforcement. Each of the Parties acknowledges and agrees that monetary damages would not adequately
compensate an injured Party for the breach of this Agreement by any Party, that this Agreement shall be specifically enforceable
and that any breach or threatened breach of this Agreement shall be the proper subject of a temporary or permanent injunction or
restraining order without a requirement of posting bond. Further, each Party hereto waives any claim or defense that there is an
adequate remedy at law for such breach or threatened breach.

 

(k)              
Further Assurances. Each of the Parties hereto shall, from time to time and without further consideration,
execute such further instruments and take such other actions as any other Party hereto shall reasonably request in order to fulfill
its obligations under this Agreement to effectuate the purposes of this Agreement, including to ensure that the obligations of
the Company under this Agreement survive and bind any successor of the Company (including as a result of an acquisition of the
Company).

 

[Signature Page Follows.]

 

    6

     

    

 

IN WITNESS WHEREOF,
the Parties hereto execute this Agreement, effective as of the date first above written.

 

	 	ARCHROCK, INC.
	 	 	 
	 	By:	/s/ D. Bradley Childers
	 	Name:	D. Bradley Childers
	 	Title:	President and Chief Executive Officer
	 	 	 
	 	 	 
	 	JDH CAPITAL HOLDINGS, L.P.
	 	 	 
	 	By: JDH Capital Company, its general partner
	 	 	 
	 	By:	/s/ Ryan Connelly
	 	Name:  	Ryan Connelly
	 	Title:	Managing Director

 

Signature Page
to Board Representation Agreement

 

     

     

    

 

Annex A

Form of Confidentiality and Non-Disclosure Agreement

 

This Confidentiality
and Non-Disclosure Agreement (this “Agreement”) is made this August 1, 2019, by and between Archrock, Inc.
(the “Company”) and Jeffery D. Hildebrand (the “Recipient”). The Company and the Recipient
are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

 

WHEREAS, the Recipient
is a member of the Board of Directors (“Board”) of the Company or a person who may be granted by the Board,
from time to time, the opportunity to attend meetings of the Board and to receive materials delivered to members of the Board;

 

WHEREAS, in connection
with such activities, the Recipient may receive certain information considered to be proprietary or confidential by the Company;
and

 

WHEREAS, the Parties
desire to maintain the confidentiality of information provided by the Company to the Recipient and to provide a procedure designed
to protect such proprietary or confidential information from unauthorized use and disclosure.

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual covenants contained herein, the Parties agree as follows:

 

1.                 
The term “Information,” as used in this Agreement, shall mean any and all non-public, confidential and/or
proprietary information furnished or disclosed, on or after the date hereof, to the Recipient by the Company or on the Company’s
behalf, whether such information is written, oral or graphic, and whether included in any analyses, compilations, studies, reports,
or other documents or presentations, including but not limited to, financial plans and records, marketing plans, business strategies
and relationships with third parties, present and proposed products, trade secrets, information regarding customers and suppliers,
strategic planning and systems, and contractual terms.

 

2.                 
Except to the extent set forth in a written consent to disclosure of Information from the Board, the Recipient shall consider
the Information received from the Company confidential and proprietary, shall take all reasonable actions to protect and maintain
the confidentiality of such Information and protect such Information from disclosure in any form whatsoever. Such actions shall
include, without limitation, not discussing the Information with any present or past stockholder or employee of the Company who
is not subject to an agreement with the Company in the same form as this Agreement without the prior written consent of the Board;
provided, however, that the parties agree that, so long as the Recipient is a member of the Board, he or she shall be entitled
to discuss Information with present employees of the Company in the exercise of her or his duties as a member of the Board.

 

3.                 
Notwithstanding anything contained in this Agreement to the contrary, the Recipient may disclose the Information received
from the Company with the individuals listed on Schedule A hereto.1

 

 

1
Schedule A to include the designee’s counsel and officers, employees and professional advisors of JDH Capital (including
legal, tax and accounting advisors and Jason Rebrook).

 

    A-1

     

    

 

4.                 
Following receipt of a written request from the Board, the Recipient shall deliver to the Company or destroy (at the Recipient’s
option) any copies of the Information in the Recipient’s possession, and the Recipient shall certify in writing to its compliance
with this Section 4. Notwithstanding the foregoing, however, the Recipient may retain copies of the Information for reasonable
legal or regulatory purposes.

 

5.                 
The Parties agree that no failure or delay by a Party in exercising any right, power or privilege under this Agreement shall
operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof.

 

6.                 
Notwithstanding anything to the contrary, the term “Information” shall not include any information that:

 

		a.	is or becomes generally known or available to the public through no breach hereof by the Recipient;

 

		b.	was lawfully obtained by the Recipient other than in her or his capacity as a member of the Board;

 

		c.	was independently developed by or for the Recipient, or acquired by the Recipient, without any
use of or reference to such Information; or

 

		d.	was obtained from, or available to the Recipient by, a third party which, to the Recipient’s
knowledge, was not bound by any confidentiality obligation to Company which would prohibit such third party from disclosing such
information to the Recipient.

 

7.                 
In the event that the Recipient is compelled, requested or required (orally or in writing) by a regulatory authority, law,
regulation, oral questions, requests for information or documents, interrogatories, subpoena, court order, deposition, administrative
proceeding, inspection, audit, civil investigative demand, formal or informal investigation by any government authority or agency
or other similar legal process to disclose any Information, the Recipient shall provide to the Company in writing prompt notice
(if legally permissible and practicable) of any such request or requirement so that the Company may, at its own cost, intervene
and seek an appropriate protective order or waive certain of the Recipient’s obligations under this Agreement. Failing the
entry of a protective order or the receipt of a waiver hereunder, if the Recipient, on the advice of its counsel, is required or
compelled to disclose Information, the Parties agree that the Recipient may disclose that portion of Information that, on the advice
of the Recipient’s counsel, the Recipient is required or compelled to disclose. In any event, the Recipient shall reasonably
cooperate with the Company, at the Company’s own cost, to obtain an appropriate protective order or other reliable assurance
that confidential treatment will be accorded the Information.

  

    A-2

     

    

 

8.                 
This Agreement constitutes the entire agreement of the Parties with respect to any obligation which the Parties have to
protect Information disclosed to them, and supersedes any prior or contemporaneous agreements and understandings in connection
therewith. This Agreement may be amended, waived, revoked or terminated only by a written agreement signed by both Parties which
makes specific reference to this Agreement.

 

9.                 
The Parties acknowledge and agree that the Company may be irreparably damaged by any breach of this Agreement. In addition
to the rights and remedies otherwise available at law or in equity, the Parties agree that the Company shall be entitled to seek
equitable relief, including an injunction or specific performance, in the event of any breach of this Agreement by the Recipient.
Further, in the event that the Board determines that the Recipient has breached this Agreement, at the request of the Board, the
Recipient shall tender his or her resignation from the Board.

 

10.                 
This Agreement may be executed in multiple counterparts each of which shall be deemed an original hereof and all of which
when taken together shall constitute one and the same document. The provisions of this Agreement shall be in addition to, and shall
not in any way reduce or modify, the duties of any member of the Board with respect to the matters contained herein under the Company’s
certificate of incorporation or bylaws or under applicable Delaware fiduciary or other law.

 

11.                 
This Agreement shall be governed by the laws of the State of Delaware, without regard to conflicts of law principles.

 

IN WITNESS WHEREOF,
the Parties have caused this Agreement to be executed as of the date first written above.

 

ARCHROCK,
INC.

 

 

	By:	/s/ D. Bradley Childers	 	 	/s/ Jeffery D. Hildebrand	 
	Name:	D. Bradley Childers	 	 	Name of Recipient: Jeffery D. Hildebrand
	Title:	president
    and chief executive officer	 	 	 

 

    A-3

     

    

 

Annex B

Conflicts of Interest

 

		·	Any matter relating to Hilcorp Energy Company, Harvest Midstream Company or any of their Affiliates,
including matters related to providing services to such parties.

 

		·	Pricing terms of contract compression services, rental of equipment, aftermarket services, parts sales,
compression installation services and ancillary services (collectively, “Pricing Terms”) provided by the Company
to its customers.

 

		·	Allocations of capital expenditures or horsepower in support of commercial relationships of the Company.

 

		·	Information with respect to potential mergers, acquisitions, divestitures and purchase-leaseback opportunities,
to the extent of Pricing Terms or specific, confidential customer information contained therein.

 

		·	Pricing terms from the Company’s major suppliers.

 

    B-1Exhibit 10.2

 

Execution Version 

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION RIGHTS
AGREEMENT, dated as of August 1, 2019 (this “Agreement”), is entered into by and between Archrock, Inc., a Delaware
corporation (the “Company”), and JDH Capital Holdings, L.P., a Texas limited partnership (“JDH”).

 

WHEREAS, this Agreement
is entered into in connection with the transactions contemplated by that certain Asset Purchase Agreement (the “Purchase
Agreement”), dated as of June 23, 2019, by and among the Company, Archrock Services, L.P., a Delaware limited partnership
and a wholly owned subsidiary of the Company, and Elite Compression Services, LLC, a Delaware limited liability company (“ECS”),
pursuant to which the Company agreed to purchase and acquire from ECS, and ECS agreed to sell and convey to the Company, certain
assets and liabilities, in exchange for (i) an amount of cash equal to $205,000,000 and (ii) 21,656,683 newly issued shares of
common stock, par value $0.01 per share (“Company Common Stock”), of the Company (the “Equity Consideration”)
issued to ECS’ Affiliate JDH; and

 

WHEREAS, the Company
has agreed to provide the registration and other rights set forth in this Agreement for the benefit of JDH pursuant to the Purchase
Agreement.

 

NOW THEREFORE, in consideration
of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereby agree as follows:

 

Article
I.

DEFINITIONS

 

Section 1.01       
Definitions. As used in this Agreement, the following terms have the meanings indicated:

 

“Affiliate”
means, with respect to any Person, any other Person that directly or indirectly through one or more intermediaries controls, is
controlled by or is under common control with, the Person in question. As used herein, the term “control” means the
possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether
through ownership of voting securities, by contract or otherwise. Notwithstanding anything in this definition to the contrary,
for purposes of this Agreement, the Company and its subsidiaries, on the one hand, and Holder, on the other hand, shall not be
considered Affiliates.

 

“Agreement”
has the meaning set forth in the introductory paragraph of this Agreement.

 

“Business
Day” means any day other than a Saturday, Sunday, any federal legal holiday or day on which banking institutions in the
State of New York or the State of Texas are authorized or required by law or other governmental action to close.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Company”
has the meaning set forth in the introductory paragraph of this Agreement.

 

“Company Common
Stock” has the meaning set forth in the Recitals of this Agreement.

 

     

     

    

 

“ECS”
has the meaning set forth in the Recitals of this Agreement.

 

“Effective
Date” means the date of effectiveness of any Registration Statement.

 

“Effectiveness
Period” has the meaning specified in Section 2.01(a).

 

“Equity Consideration”
has the meaning set forth in the Recitals of this Agreement.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations of the Commission
promulgated thereunder.

 

“Holder”
means a holder of Registrable Securities.

 

“Holder Underwriter
Registration Statement” has the meaning specified in Section 2.04(q).

 

“Included
Registrable Securities” has the meaning specified in Section 2.02(a).

 

“Initiating
Holder” has the meaning specified in Section 2.03(b).

 

“Issue Price”
means $9.4659 per share of Company Common Stock.

 

“JDH”
has the meaning set forth in the introductory paragraph of this Agreement.

 

“Losses”
has the meaning specified in Section 2.08(a).

 

“Managing
Underwriter” means, with respect to any Underwritten Offering, the book running lead manager of such Underwritten Offering.

 

“National
Securities Exchange” means either the New York Stock Exchange, the Nasdaq Stock Market, an exchange registered with the
Commission under Section 6(a) of the Exchange Act (or any successor to such Section) or any other securities exchange (whether
or not registered with the Commission under Section 6(a) (or successor to such Section) of the Exchange Act) on which shares of
Company Common Stock are then listed.

 

“Other Holder”
has the meaning specified in Section 2.02(a).

 

“Person”
means any individual, corporation, company, voluntary association, partnership, joint venture, trust, limited liability company,
unincorporated organization, government or any agency, instrumentality or political subdivision thereof or any other form of entity.

 

“Piggyback
Notice” has the meaning specified in Section 2.02(a).

 

“Piggyback
Opt-Out Notice” has the meaning specified in Section 2.02(a).

 

“Piggyback
Registration” has the meaning specified in Section 2.02(a).

 

“Purchase
Agreement” has the meaning set forth in the Recitals of this Agreement.

 

     

     

    

 

“Registrable
Securities” means (i) the shares of Company Common Stock beneficially owned by JDH, its permitted transferees or its
or their respective Affiliates (provided, that with respect to shares of Company Common Stock acquired by JDH or its Affiliates
after the date hereof, only shares of Company Common Stock acquired while JDH is an “affiliate” of the Company (as
defined in Rule 144 promulgated under the Securities Act) shall be Registrable Securities; provided, further, that
with respect to shares of Company Common Stock beneficially owned by permitted transferees (other than, for the avoidance of doubt,
JDH’s Affiliates), such shares shall only include shares of Company Common Stock beneficially owned by JDH as of the date
hereof and transferred to such permitted transferee in accordance with this Agreement), including, for the avoidance of doubt,
the shares of Company Common Stock representing the Equity Consideration, and (ii) any securities issued or issuable with respect
thereto by way of conversion, exchange, replacement, stock dividend, stock split or other distribution or in connection with a
combination of stock, recapitalization, merger, consolidation or other reorganization or otherwise.

 

“Registrable
Securities Required Voting Percentage” means a majority of the outstanding Registrable Securities.

 

“Registration”
means any registration pursuant to this Agreement, including pursuant to a Registration Statement or a Piggyback Registration.

 

“Registration
Expenses” has the meaning specified in Section 2.07(a).

 

“Registration
Statement” has the meaning specified in Section 2.01(a).

 

“Securities
Act” means the Securities Act of 1933, as amended from time to time, and the rules and regulations of the Commission
promulgated thereunder.

 

“Selling Expenses”
has the meaning specified in Section 2.07(a).

 

“Selling Holder”
means a Holder who is selling Registrable Securities pursuant to a Registration Statement.

 

“Selling Holder
Indemnified Persons” has the meaning specified in Section 2.08(a).

 

“Target Effective
Date” has the meaning specified in Section 2.01(a).

 

“Underwriter”
means, with respect to any Underwritten Offering, the underwriters of such Underwritten Offering.

 

“Underwritten
Offering” means an offering (including an offering pursuant to a Registration Statement) in which shares of Company Common
Stock are sold to an Underwriter on a firm commitment basis for reoffering to the public or an offering that is a “bought
deal” with one or more investment banks.

 

“WKSI”
means a well-known seasoned issuer (as defined in the rules and regulations of the Commission).

 

Section 1.02       
Registrable Securities. Any Registrable Security will cease to be a Registrable Security upon the earliest to occur
of the following: (a) when a registration statement covering such Registrable Security becomes or has been declared effective
by the Commission and such Registrable Security has been sold or disposed of pursuant to such effective registration statement,
(b) when such Registrable Security has been disposed of (excluding transfers or assignments by a Holder to an Affiliate or to
another Holder or any of its Affiliates or to any assignee or transferee to whom the rights under this Agreement have been transferred
pursuant to Section 2.10) pursuant to any section of Rule 144 (or any similar provision then in effect) under the Securities
Act, (c) when such Registrable Security is held by the Company or any of its respective direct or indirect subsidiaries, (d) when
such Registrable Security has been sold or disposed of in a private transaction in which the transferor’s rights under this
Agreement are not assigned to the transferee of such securities pursuant to Section 2.10 and (e) the date that is three
years after the date that JDH is no longer an “affiliate” of the Company (as defined in Rule 144 promulgated under
the Securities Act).

 

     

     

    

 

Article
II.

REGISTRATION RIGHTS

 

Section
2.01          Shelf
Registration.

 

(a)          Shelf Registration. The Company shall use its commercially reasonable efforts to (i) prepare and file an initial
registration statement under the Securities Act prior to the date that is six (6) months after the date hereof to permit the resale
of Registrable Securities from time to time as permitted by Rule 415 (or any similar provision adopted by the Commission then in
effect) of the Securities Act (a “Registration Statement”) and (ii) cause such initial Registration Statement
to become effective as soon as practicable after filing thereof and in no event later than the date that is six (6) months after
the date hereof (the “Target Effective Date”). The Company will use its commercially reasonable efforts to cause
the Registration Statement filed pursuant to this Section 2.01(a) to be continuously effective under the Securities Act,
with respect to any Holder, until the date on which there are no longer any Registrable Securities outstanding (the “Effectiveness
Period”). A Registration Statement filed pursuant to this Section 2.01(a) shall be on such appropriate registration
form of the Commission as shall be selected by the Company; provided that, if the Company is then eligible, it shall file
such Registration Statement on Form S-3. A Registration Statement when declared effective (including the documents incorporated
therein by reference) will comply as to form in all material respects with all applicable requirements of the Securities Act and
the Exchange Act and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading (and, in the case of any prospectus contained in such Registration
Statement, in the light of the circumstances under which a statement is made). As soon as practicable following the date that a
Registration Statement becomes effective, but in any event within three Business Days of such date, the Company shall provide the
Holders with written notice of the effectiveness of such Registration Statement. The Company shall not be obligated to maintain
more than one effective Registration Statement at any given time pursuant to this Section 2.01.

 

(b)          Delay Rights. Notwithstanding anything to the contrary contained herein, the Company may, upon written notice to
any Selling Holder whose Registrable Securities are included in a Registration Statement, suspend such Selling Holder’s use
of any prospectus which is a part of such Registration Statement (in which event the Selling Holder shall suspend sales of the
Registrable Securities pursuant to such Registration Statement) if (i) the Company is pursuing an acquisition, merger, reorganization,
disposition or other similar transaction and the Company determines in good faith that the Company’s ability to pursue or
consummate such a transaction would be materially and adversely affected by any required disclosure of such transaction in such
Registration Statement, or (ii) the Company or any of its Affiliates has experienced some other material non-public event, the
disclosure of which at such time, in the good faith judgment of the Company, would materially and adversely affect the Company;
provided, however, that in no event shall the Selling Holders be suspended from selling Registrable Securities pursuant
to such Registration Statement for a period that exceeds an aggregate of 60 days in any 180-day period or 90 days in any 365-day
period. Upon disclosure of such information or the termination of the condition described above, the Company shall promptly provide
notice to the Selling Holders whose Registrable Securities are included in such Registration Statement, and shall promptly terminate
any suspension of sales it has put into effect and shall take such other actions necessary or appropriate to permit registered
sales of Registrable Securities as contemplated in this Agreement. For the avoidance of doubt, the provisions of this Section
2.01(b) shall apply to any Underwritten Offering undertaken pursuant to Section 2.03.

 

     

     

    

 

Section 2.02       
Piggyback Registration.

 

(a)          Participation. If at any time the Company proposes to file (i) a Registration Statement (other than a Registration
Statement contemplated by Section 2.01(a)) on behalf of any other Person who has registration rights related to an Underwritten
Offering (the “Other Holder”) or (ii) a prospectus supplement relating to the sale of shares of Company Common
Stock by any Other Holders pursuant to an effective registration statement, so long as the Company is a WKSI at such time or, whether
or not the Company is a WKSI, so long as the Registrable Securities were previously included in the underlying shelf Registration
Statement or are included on an effective Registration Statement, or in any case in which Holders may participate in such offering
without the filing of a post-effective amendment, in each case, for the sale of shares of Company Common Stock by the Company and/or
Other Holders in an Underwritten Offering, then the Company shall give not less than four Business Days’ notice (including,
but not limited to, notification by electronic mail) (the “Piggyback Notice”) of such proposed Underwritten
Offering to each Holder that, together with its Affiliates, owns at least $15 million of Registrable Securities and such Piggyback
Notice shall offer such Holder the opportunity to include in such Underwritten Offering for Other Holders such number of Registrable
Securities (the “Included Registrable Securities”) as such Holder may request in writing (a “Piggyback
Registration”); provided, however, that the Company shall not be required to offer such opportunity (A)
to such Holders if the Holders, together with their Affiliates, do not offer a minimum of $15 million of Registrable Securities,
in the aggregate (determined by multiplying the number of Registrable Securities owned by the average of the closing price on the
National Securities Exchange for shares of Company Common Stock for the 10 trading days preceding the date of such Piggyback Notice),
or such lesser amount if it constitutes the remaining holdings of the Holder and its Affiliates, or (B) to such Holders if and
to the extent that the Company has been advised by the Managing Underwriter in writing that the inclusion of Registrable Securities
for sale for the benefit of such Holders will have an adverse effect on the price, timing or distribution of the shares of Company
Common Stock in such Underwritten Offering, then the amount of Registrable Securities to be offered for the accounts of Holders
shall be determined based on the provisions of Section 2.02(b). Each Piggyback Notice shall be provided to Holders on a
Business Day pursuant to Section 3.01 and receipt of such Piggyback Notice shall be confirmed and kept confidential by the
Holders until either (x) such proposed Underwritten Offering has been publicly announced by the Company or (y) the Holders have
received notice from the Company that such proposed Underwritten Offering has been abandoned, which the Company shall provide to
the Holders reasonably promptly after the final decision to abandon such proposed Underwritten Offering has been made. Each such
Holder will have four Business Days (or two Business Days in connection with any overnight or bought Underwritten Offering) after
such Piggyback Notice has been delivered to request in writing to the Company the inclusion of Registrable Securities in the Underwritten
Offering for Other Holders. If no request for inclusion from a Holder is received by the Company within the specified time or if
a Holder states in its response to the Piggyback Notice that it declines the opportunity to include Registrable Securities in the
Underwritten Offering, such Holder shall have no further right to participate in such Underwritten Offering. If, at any time after
giving written notice of the Company’s intention to undertake an Underwritten Offering for Other Holders and prior to the
pricing of such Underwritten Offering, such Underwritten Offering is terminated or delayed pursuant to the provisions of this Agreement,
the Company may, at its election, give written notice of such determination to the Selling Holders and, (1) in the case of a termination
of such Underwritten Offering, shall be relieved of its obligation to sell any Included Registrable Securities in connection with
such terminated Underwritten Offering, and (2) in the case of a determination to delay such Underwritten Offering, shall be permitted
to delay offering any Included Registrable Securities for the same period as the delay in the Underwritten Offering. Any Selling
Holder shall have the right to withdraw such Selling Holder’s request for inclusion of such Selling Holder’s Registrable
Securities in such Underwritten Offering by giving written notice to the Company of such withdrawal at least one Business Day prior
to the time of pricing of such Underwritten Offering. Any Holder may deliver written notice (a “Piggyback Opt-Out Notice”)
to the Company requesting that such Holder not receive notice from the Company of any proposed Underwritten Offering for Other
Holders; provided, however, that such Holder may later revoke any such Piggyback Opt-Out Notice in writing. Following
receipt of a Piggyback Opt-Out Notice from a Holder (unless subsequently revoked), the Company shall not be required to deliver
any notice to such Holder pursuant to this Section 2.02(a) and such Holder shall no longer be entitled to participate in
any Underwritten Offering for Other Holders pursuant to this Section 2.02(a), unless such Piggyback Opt-Out Notice is revoked
by such Holder.

 

     

     

    

 

(b)          Priority of Piggyback Registration. If the Managing Underwriter or Underwriters of any proposed Underwritten Offering
for Other Holders advise the Company in writing that the total amount of Registrable Securities that Holders intend to include
in such offering exceeds the number that can be sold in such offering without being likely to have an adverse effect on the price,
timing or distribution of the Registrable Securities offered or the market for the shares of Company Common Stock, then the Company
shall include the number of shares of Company Common Stock that such Managing Underwriter or Underwriters advise the Company can
be sold without having such adverse effect, with such number to be allocated (i) in the event that the Person that initiated such
Underwritten Offering is the Company, (A) first, to the Company, (B) second, pro rata among (1) any Holders who are exercising
piggyback registration rights pursuant to this Section 2.02 related to such offering and (2) any Persons owning shares of
Company Common Stock, having piggyback registration rights pari passu to those of the Holders described in this Section
2.02(b)(i)(B) and exercising such piggyback registration rights and (C) third, pro rata among any Persons owning shares of
Company Common Stock having piggyback registration rights subordinate to those of the Holders and exercising such piggyback registration
rights and (ii) in the event that any Person other than the Company initiated such Underwritten Offering, (A) first, to the Person
that initiated such Underwritten Offering, (B) second, pro rata among (1) all other Holders who are exercising piggyback registration
rights pursuant to this Section 2.02 related to such offering and (2) any Persons owning shares of Company Common Stock,
having piggyback registration rights pari passu to those of the Holders described in this Section 2.02(b)(ii) and
exercising such piggyback registration rights and (C) third, pro rata among the Company (to the extent that such Person was not
the Person initiating the Underwritten Offering on its own behalf) and Persons owning shares of Company Common Stock having piggyback
registration rights subordinate to those of the Holders and exercising such piggyback registration rights (it being understood
that “pro rata,” as used in this Section 2.02, is based, for each such Person or Holder, as applicable, on the
percentage derived by dividing (x) the number of shares of Company Common Stock proposed to be sold by such Person or Holder, as
applicable, in such offering by (y) the aggregate number of shares of Company Common Stock proposed to be sold by the Persons sharing
in the same tier of pro rata allocation).

 

     

     

    

 

Section 2.03       
Underwritten Offering.

 

(a)          S-3 Registration. In the event that any Holder elects to dispose of Registrable Securities under a Registration Statement
pursuant to an Underwritten Offering and either (i) reasonably expects gross proceeds of at least $50 million from such Underwritten
Offering (together with any Registrable Securities to be disposed of by a Selling Holder who has elected to participate in such
Underwritten Offering pursuant to Section 2.02) or (ii) reasonably expects gross proceeds of at least $25 million from such
Underwritten Offering (together with any Registrable Securities to be disposed of by a Selling Holder who has elected to participate
in such Underwritten Offering pursuant to Section 2.02) and such Registrable Securities represent 100% of the then outstanding
Registrable Securities held by the applicable Selling Holder and Affiliates, the Company shall, at the written request of such
Selling Holder(s), enter into an underwriting agreement in a form as is customary in Underwritten Offerings of securities by the
Company with the Managing Underwriter or Underwriters selected by the Company after consultation with the Holders of a majority
of the Registrable Securities included in such Underwritten Offering, which shall include, among other provisions, indemnities
to the effect and to the extent provided in Section 2.08, and shall take all such other reasonable actions as are requested
by the Managing Underwriter or Underwriters in order to expedite or facilitate the disposition of such Registrable Securities;
provided, however, that no Selling Holder may demand an Underwritten Offering within 90 days of another Underwritten
Offering; provided, further, that if the Company or its Affiliates are conducting or actively pursuing a securities
offering of shares of Company Common Stock with anticipated gross offering proceeds of at least $50 million (other than in connection
with any at-the-market offering or similar continuous offering program), then the Company may suspend such Selling Holder’s
right to require the Company to conduct an Underwritten Offering on such Selling Holder’s behalf pursuant to this Section
2.03; provided, however, that the Company shall have no obligation to facilitate or participate in, including entering
into any underwriting agreement for, more than three Underwritten Offerings at the request of the Holders in any 365-day period;
provided, further, that the Company may only suspend such Selling Holder’s right to require the Company to
conduct an Underwritten Offering pursuant to this Section 2.03 once in any six-month period and in no event for a period
that exceeds an aggregate of 45 days in any 180-day period or 75 days in any 365-day period; provided, further, that to
the extent the Company suspends a Selling Holder’s right to require the Company to conduct an Underwritten Offering pursuant
to this Section 2.03, and either (x) (A) such Selling Holder subsequently elects to participate in such Company Underwritten
Offering pursuant to Section 2.02(a) and (B) the amount of Registrable Securities such Selling Holder elects to sell by
participating in such Company Underwritten Offering is reduced (pursuant to Section 2.02(b)) by more than 50% or (y) such
Selling Holder does not, or is unable to, participate in such Company Underwritten Offering pursuant to Section 2.02(a),
such Selling Holder shall not be subject to the 90 day prohibition described in this paragraph on subsequent Underwritten Offerings
until such Selling Holder’s next demand for an Underwritten Offering pursuant to this Section 2.03.

 

     

     

    

 

(b)          General Procedures. In connection with any Underwritten Offering contemplated by Section 2.03(a), the underwriting
agreement into which each Selling Holder and the Company shall enter shall contain such representations, covenants, indemnities
(subject to Section 2.08) and other rights and obligations as are customary in Underwritten Offerings of securities by the
Company. No Selling Holder shall be required to make any representations or warranties to, or agreements with, the Company or the
Underwriters other than representations, warranties or agreements regarding such Selling Holder’s authority to enter into
such underwriting agreement and to sell, and its ownership of, the securities being registered on its behalf, its intended method
of distribution and any other representation required by law. If any Selling Holder disapproves of the terms of an Underwritten
Offering contemplated by this Section 2.03, such Selling Holder may elect to withdraw therefrom by notice to the Company
and the Managing Underwriter; provided, however, that such withdrawal must be made at least one Business Day prior
to the time of pricing of such Underwritten Offering to be effective; provided, further, that in the event the Managing
Underwriter or Underwriters of any proposed Underwritten Offering advise the Company that the total amount of Registrable Securities
that Holders intend to include in such offering exceeds the number that can be sold in such offering without being likely to have
an adverse effect on the price, timing or distribution of the Common Unit Registrable Securities offered or the market for shares
of Company Common Stock, and the amount of Common Unit Registrable Securities requested to be included in such Underwritten Offering
by the Holder that initiated such Underwritten Offering pursuant to Section 2.03(a) (the “Initiating Holder”)
is reduced by 50% or more, the Initiating Holder will have the right to withdraw from such Underwritten Offering by delivering
notice to the Company at least one Business Day prior to the time of pricing of such Underwritten Offering, in which case the Company
will have no obligation to proceed with such Underwritten Offering and such Underwritten Offering, whether or not completed, will
not decrease the number of Underwritten Offerings the Initiating Holder shall have the right and option to request under this Section
2.03. No such withdrawal or abandonment shall affect the Company’s obligation to pay Registration Expenses.

 

Section 2.04       
Further Obligations. In connection with its obligations under this Article II, the Company will:

 

(a)          promptly prepare and file with the Commission such amendments and supplements to a Registration Statement and the prospectus
used in connection therewith as may be necessary to keep such Registration Statement effective for the Effectiveness Period and
as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
covered by such Registration Statement;

 

     

     

    

 

(b)          if a prospectus supplement will be used in connection with the marketing of an Underwritten Offering under a Registration
Statement and the Managing Underwriter at any time shall notify the Company in writing that, in the sole judgment of such Managing
Underwriter, inclusion of detailed information to be used in such prospectus supplement is of material importance to the success
of such Underwritten Offering, use its commercially reasonable efforts to include such information in such prospectus supplement;

 

(c)          furnish to each Selling Holder (i) as far in advance as reasonably practicable before filing a Registration Statement or
any other registration statement contemplated by this Agreement or any supplement or amendment thereto, upon request, copies of
reasonably complete drafts of all such documents proposed to be filed (including exhibits and each document incorporated by reference
therein to the extent then required by the rules and regulations of the Commission), and provide each such Selling Holder the opportunity
to object to any information pertaining to such Selling Holder and its plan of distribution that is contained therein and, to the
extent timely received, make the corrections reasonably requested by such Selling Holder with respect to such information prior
to filing such Registration Statement or such other registration statement and the prospectus included therein or any supplement
or amendment thereto, and (ii) such number of copies of such Registration Statement or such other registration statement and the
prospectus included therein and any supplements and amendments thereto as such Persons may reasonably request in order to facilitate
the resale or other disposition of the Registrable Securities covered by such Registration Statement or other registration statement;

 

(d)          if applicable, use its commercially reasonable efforts to promptly register or qualify the Registrable Securities covered
by any Registration Statement or any other registration statement contemplated by this Agreement under the securities or blue sky
laws of such jurisdictions as the Selling Holders or, in the case of an Underwritten Offering, the Managing Underwriter, shall
reasonably request; provided, however, that the Company will not be required to qualify generally to transact business
in any jurisdiction where it is not then required to so qualify or to take any action that would subject it to general service
of process in any such jurisdiction where it is not then so subject;

 

(e)          promptly notify each Selling Holder, at any time when a prospectus relating thereto is required to be delivered by any of
them under the Securities Act, of (i) the filing of a Registration Statement or any other registration statement contemplated by
this Agreement or any prospectus or prospectus supplement to be used in connection therewith, or any amendment or supplement thereto,
and, with respect to a Registration Statement or any other registration statement or any post-effective amendment thereto, when
the same has become effective; and (ii) the receipt of any written comments from the Commission with respect to any filing referred
to in clause (i) and any written request by the Commission for amendments or supplements to any such Registration Statement or
any other registration statement or any prospectus or prospectus supplement thereto;

 

     

     

    

 

(f)           promptly notify each Selling Holder, at any time when a prospectus relating thereto is required to be delivered by any of
them under the Securities Act, of (i) the happening of any event as a result of which the prospectus or prospectus supplement contained
in a Registration Statement or any other registration statement contemplated by this Agreement, as then in effect, includes an
untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the
statements therein not misleading (in the case of any prospectus contained therein, in the light of the circumstances under which
a statement is made); (ii) the issuance or express threat of issuance by the Commission of any stop order suspending the effectiveness
of a Registration Statement or any other registration statement contemplated by this Agreement, or the initiation of any proceedings
for that purpose; or (iii) the receipt by the Company of any notification with respect to the suspension of the qualification of
any Registrable Securities for sale under the applicable securities or blue sky laws of any jurisdiction. Following the provision
of such notice, the Company agrees to, as promptly as practicable, amend or supplement the prospectus or prospectus supplement
or take other appropriate action so that the prospectus or prospectus supplement does not include an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading
in the light of the circumstances then existing and to take such other action as is reasonably necessary to remove a stop order,
suspension, threat thereof or proceedings related thereto;

 

(g)          upon request and subject to appropriate confidentiality obligations, furnish to each Selling Holder copies of any and all
transmittal letters or other correspondence with the Commission or any other governmental agency or self-regulatory body or other
body having jurisdiction (including any domestic or foreign securities exchange) relating to such offering of Registrable Securities;

 

(h)          in the case of an Underwritten Offering, furnish, or use its commercially reasonable efforts to cause to be furnished, upon
request, (i) an opinion of counsel for the Company addressed to the Underwriters, dated as of the date of the closing under the
applicable underwriting agreement and (ii) a “comfort letter” addressed to the Underwriters, dated as of the pricing
date of such Underwritten Offering and a letter of like kind dated as of the date of the closing under the applicable underwriting
agreement, in each case, signed by the independent public accountants who have certified the Company’s financial statements
included or incorporated by reference into the applicable registration statement, and each of the opinion and the “comfort
letter” shall be in customary form and covering substantially the same matters with respect to such registration statement
(and the prospectus and any prospectus supplement) as have been customarily covered in opinions of issuer’s counsel and in
accountants’ letters delivered to the Underwriters in Underwritten Offerings of securities by the Company and such other
matters as such Underwriters may reasonably request;

 

(i)           otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission;

 

(j)           make available to the appropriate representatives of the Managing Underwriter during normal business hours access to such
information and Company personnel as is reasonable and customary to enable such parties to establish a due diligence defense under
the Securities Act; provided, however, that the Company need not disclose any non-public information to any such
representative unless and until such representative has entered into a confidentiality agreement with the Company;

 

     

     

    

 

(k)          use its commercially reasonable efforts to cause all Common Unit Registrable Securities registered pursuant to this Agreement
to be listed on each securities exchange or nationally recognized quotation system on which similar securities issued by the Company
are then listed;

 

(l)           use its commercially reasonable efforts to cause Registrable Securities to be registered with or approved by such other
governmental agencies or authorities as may be necessary by virtue of the business and operations of the Company to enable the
Selling Holders to consummate the disposition of such Registrable Securities;

 

(m)         provide a transfer agent and registrar for all Registrable Securities covered by any Registration Statement not later than
the Effective Date of such Registration Statement;

 

(n)          enter into customary agreements and take such other actions as are reasonably requested by the Selling Holders or the Underwriters,
if any, in order to expedite or facilitate the disposition of Registrable Securities (including making appropriate officers of
the Company available to participate in customary marketing activities); provided, however, that the officers of
the Company shall not be required to dedicate an unreasonably burdensome amount of time in connection with any roadshow and related
marketing activities for any Underwritten Offering;

 

(o)          if reasonably requested by a Selling Holder, (i) incorporate in a prospectus supplement or post-effective amendment such
information as such Selling Holder reasonably requests to be included therein relating to the sale and distribution of Registrable
Securities, including information with respect to the number of Registrable Securities being offered or sold, the purchase price
being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; and (ii) make
all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated
in such prospectus supplement or post-effective amendment;

 

(p)          if reasonably required by the Company’s transfer agent, promptly deliver any authorizations, certificates and directions
required by the transfer agent which authorize and direct the transfer agent to transfer such Registrable Securities without legend
upon sale by the Holder of such Registrable Securities under the Registration Statement; and

 

(q)          if any Holder could reasonably be deemed to be an “underwriter,” as defined in Section 2(a)(11) of the Securities
Act, in connection with the Registration Statement and any amendment or supplement thereof (a “Holder Underwriter Registration
Statement”), then reasonably cooperate with such Holder in allowing such Holder to conduct customary “underwriter’s
due diligence” with respect to the Company and satisfy its obligations in respect thereof. In addition, at any Holder’s
request, the Company will furnish to such Holder, on the date of the effectiveness of the Holder Underwriter Registration Statement
and thereafter from time to time on such dates as such Holder may reasonably request (provided that such request shall not be more
frequently than on an annual basis unless such Holder is offering Registrable Securities pursuant to a Holder Underwriter Registration
Statement), (i) a “comfort letter”, dated as of such date, from the Company’s independent certified public accountants
in form and substance as has been customarily given by independent certified public accountants to underwriters in Underwritten
Offerings of securities by the Company, addressed to such Holder, (ii) an opinion, dated as of such date, of counsel representing
the Company for purposes of the Holder Underwriter Registration Statement, in form, scope and substance as has been customarily
given in Underwritten Offerings of securities by the Company, including standard “10b-5” negative assurance for such
offerings, addressed to such Holder and (iii) a standard officer’s certificate from the chief executive officer or chief
financial officer, or other officers serving such functions, of the Company addressed to the Holder, as has been customarily given
by such officers in Underwritten Offerings of securities by the Company. The Company will also use its commercially reasonable
efforts to provide legal counsel to such Holder with an opportunity to review and comment upon any such Holder Underwriter Registration
Statement, and any amendments and supplements thereto, prior to its filing with the Commission.

 

     

     

    

 

Notwithstanding anything
to the contrary in this Section 2.04, the Company will not name a Holder as an underwriter (as defined in Section 2(a)(11)
of the Securities Act) in any Registration Statement or Holder Underwriter Registration Statement, as applicable, without such
Holder’s consent. If the staff of the Commission requires the Company to name any Holder as an underwriter (as defined in
Section 2(a)(11) of the Securities Act), and such Holder does not consent thereto, then such Holder’s Registrable Securities
shall not be included on the applicable Registration Statement, and the Company shall have no further obligations hereunder with
respect to Registrable Securities held by such Holder, unless such Holder has not had an opportunity to conduct customary underwriter’s
due diligence as set forth in Section 2.04(q) with respect to the Company at the time such Holder’s consent is sought.

 

Each Selling Holder,
upon receipt of notice from the Company of the happening of any event of the kind described in Section 2.04(f), shall forthwith
discontinue offers and sales of the Registrable Securities by means of a prospectus or prospectus supplement until such Selling
Holder’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 2.04(f) or until
it is advised in writing by the Company that the use of the prospectus may be resumed and has received copies of any additional
or supplemental filings incorporated by reference in the prospectus, and, if so directed by the Company, such Selling Holder will,
or will request the Managing Underwriter or Managing Underwriters, if any, to deliver to the Company (at the Company’s expense)
all copies in their possession or control, other than permanent file copies then in such Selling Holder’s possession, of
the prospectus covering such Registrable Securities current at the time of receipt of such notice.

 

Section 2.05       
Cooperation by Holders. The Company shall have no obligation to include Registrable Securities of a Holder in a
Registration Statement or in an Underwritten Offering pursuant to Section 2.03(a) if such Holder
has failed to timely furnish such information that the Company determines, after consultation with its counsel, is reasonably
required in order for any registration statement or prospectus supplement, as applicable, to comply with the Securities Act.

 

     

     

    

 

Section 2.06       
Restrictions on Public Sale by Holders of Registrable Securities. Each Holder of Registrable Securities who is participating
in an Underwritten Offering agrees to enter into a customary letter agreement with Underwriters providing that such Holder will
not effect any public sale or distribution of Registrable Securities during the 45 calendar day period beginning on the date of
a prospectus or prospectus supplement filed with the Commission with respect to the pricing of such Underwritten Offering; provided,
however, that, notwithstanding the foregoing, (i) the duration of the foregoing restrictions shall be no longer than the
duration of the shortest restriction imposed by the Underwriters on the Company or the officers, directors or any other Affiliate
of the Company on whom a restriction is imposed and (ii) the restrictions set forth in this Section 2.06 shall not apply
to any Registrable Securities that are included in such Underwritten Offering by such Holder.

 

Section 2.07       
Expenses.

 

(a)          Certain Definitions. “Registration Expenses” shall not include Selling Expenses but otherwise
means all expenses incident to the Company’s performance under or compliance with this Agreement to effect the registration
of Registrable Securities on a Registration Statement pursuant to Section 2.01, a Piggyback Registration pursuant to Section
2.02, or an Underwritten Offering pursuant to Section 2.03, and the disposition of such Registrable Securities, including
all registration, filing, securities exchange listing and National Securities Exchange fees, all registration, filing, qualification
and other fees and expenses of complying with securities or blue sky laws, fees of the Financial Industry Regulatory Authority,
fees of transfer agents and registrars, all word processing, duplicating and printing expenses, and the fees and disbursements
of counsel and independent public accountants for the Company, including the expenses of any special audits or “cold comfort”
letters required by or incident to such performance and compliance. “Selling Expenses” means all underwriting
fees, discounts and selling commissions and transfer taxes allocable to the sale of the Registrable Securities, plus any costs
or expenses related to any roadshows conducted in connection with the marketing of any Underwritten Offering.

 

(b)          Expenses. The Company will pay all reasonable Registration Expenses, as determined in good faith, in connection with
a shelf Registration, a Piggyback Registration or an Underwritten Offering, whether or not any sale is made pursuant to such shelf
Registration, Piggyback Registration or Underwritten Offering. Each Selling Holder shall pay its pro rata share of all Selling
Expenses in connection with any sale of its Registrable Securities hereunder. In addition, except as otherwise provided in Section
2.08, the Company shall not be responsible for professional fees (including legal fees) incurred by Holders in connection with
the exercise of such Holders’ rights hereunder.

 

Section 2.08       
Indemnification.

 

(a)          By the Company. In the event of a registration of any Registrable Securities under the Securities Act pursuant to
this Agreement, the Company will indemnify and hold harmless each Selling Holder thereunder, its directors, officers, managers,
partners, employees and agents and each Person, if any, who controls such Selling Holder within the meaning of the Securities Act
and the Exchange Act, and its directors, officers, managers, partners, employees or agents (collectively, the “Selling
Holder Indemnified Persons”), against any losses, claims, damages, expenses or liabilities (including reasonable attorneys’
fees and expenses) (collectively, “Losses”), joint or several, to which such Selling Holder Indemnified Person
may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such Losses (or actions or proceedings,
whether commenced or threatened, in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement
of any material fact (in the case of any prospectus, in light of the circumstances under which such statement is made) contained
in (which, for the avoidance of doubt, includes documents incorporated by reference in) the applicable Registration Statement or
other registration statement contemplated by this Agreement, any preliminary prospectus, prospectus supplement or final prospectus
contained therein, or any amendment or supplement thereof, or any free writing prospectus relating thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to
make the statements therein (in the case of a prospectus, in light of the circumstances under which they were made) not misleading,
and will reimburse each such Selling Holder Indemnified Person for any legal or other expenses reasonably incurred by them in connection
with investigating, defending or resolving any such Loss or actions or proceedings; provided, however, that the Company
will not be liable in any such case if and to the extent that any such Loss arises out of or is based upon an untrue statement
or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by such Selling Holder
Indemnified Person in writing specifically for use in the applicable Registration Statement or other registration statement, preliminary
prospectus, prospectus supplement or final prospectus, or amendment or supplement thereto, or any free writing prospectus relating
thereto, as applicable. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf
of such Selling Holder Indemnified Person, and shall survive the transfer of such securities by such Selling Holder.

 

     

     

    

 

(b)          By Each Selling Holder. Each Selling Holder agrees severally and not jointly to indemnify and hold harmless the Company,
the Company’s directors, officers, employees and agents and each Person, who, directly or indirectly, controls the Company
within the meaning of the Securities Act or of the Exchange Act to the same extent as the foregoing indemnity from the Company
to the Selling Holders, but only with respect to information regarding such Selling Holder furnished in writing by or on behalf
of such Selling Holder expressly for inclusion in a Registration Statement or any other registration statement contemplated by
this Agreement, any preliminary prospectus, prospectus supplement or final prospectus contained therein, or any amendment or supplement
thereto or any free writing prospectus relating thereto; provided, however, that the liability of each Selling Holder shall
not be greater in amount than the dollar amount of the proceeds (net of any Selling Expenses) received by such Selling Holder from
the sale of the Registrable Securities giving rise to such indemnification.

 

(c)          Notice. Promptly after receipt by an indemnified party hereunder of notice of the commencement of any action, such
indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying
party in writing thereof, but the omission to so notify the indemnifying party shall not relieve it from any liability that it
may have to any indemnified party other than under this Section 2.08(c), except to the extent that the indemnifying party
is materially prejudiced by such failure. In any action brought against any indemnified party, it shall notify the indemnifying
party of the commencement thereof. The indemnifying party shall be entitled to participate in and, to the extent it shall wish,
to assume and undertake the defense thereof with counsel reasonably satisfactory to such indemnified party and, after notice from
the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying
party shall not be liable to such indemnified party under this Section 2.08 for any legal expenses subsequently incurred
by such indemnified party in connection with the defense thereof other than reasonable costs of investigation and of liaison with
counsel so selected; provided, however, that, (i) if the indemnifying party has failed to assume the defense or employ
counsel reasonably satisfactory to the indemnified party or (ii) if the defendants in any such action include both the indemnified
party and the indemnifying party and counsel to the indemnified party shall have concluded that there may be reasonable defenses
available to the indemnified party that are different from or additional to those available to the indemnifying party, or if the
interests of the indemnified party reasonably may be deemed to conflict with the interests of the indemnifying party, then the
indemnified party shall have the right to select a separate counsel and to assume such legal defense and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of such separate counsel and other reasonable expenses related
to such participation to be reimbursed by the indemnifying party as incurred. Notwithstanding any other provision of this Agreement,
no indemnifying party shall settle any action brought against any indemnified party with respect to which such indemnified party
may be entitled to indemnification hereunder without the consent of the indemnified party, unless the settlement thereof imposes
no liability or obligation on, includes a complete and unconditional release from liability of, and does not contain any admission
of wrongdoing by, the indemnified party.

 

     

     

    

 

(d)          Contribution. If the indemnification provided for in this Section 2.08 is held by a court or government agency
of competent jurisdiction to be unavailable to any indemnified party or is insufficient to hold them harmless in respect of any
Losses, then each such indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid
or payable by such indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative fault
of the indemnifying party, on the one hand, and of the indemnified party, on the other hand, in connection with the statements
or omissions that resulted in such Losses, as well as any other relevant equitable considerations; provided, however,
that in no event shall any Selling Holder be required to contribute an aggregate amount in excess of the dollar amount of proceeds
(net of Selling Expenses) received by such Selling Holder from the sale of Registrable Securities giving rise to such indemnification.
The relative fault of the indemnifying party, on the one hand, and the indemnified party, on the other hand, shall be determined
by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact has been made by, or relates to, information supplied by such party, and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree
that it would not be just and equitable if contributions pursuant to this paragraph were to be determined by pro rata allocation
or by any other method of allocation that does not take account of the equitable considerations referred to herein. The amount
paid by an indemnified party as a result of the Losses referred to in the first sentence of this paragraph shall be deemed to include
any legal and other expenses reasonably incurred by such indemnified party in connection with investigating, defending or resolving
any Loss that is the subject of this paragraph. No Person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any Person who is not guilty of such fraudulent misrepresentation.

 

(e)          Other Indemnification. The provisions of this Section 2.08 shall be in addition to any other rights to indemnification
or contribution that an indemnified party may have pursuant to law, equity, contract or otherwise.

 

     

     

    

 

Section 2.09       
Rule 144 Reporting. With a view to making available the benefits of certain rules and regulations of the Commission
that may permit the resale of the Registrable Securities without registration, the Company agrees to use its commercially reasonable
efforts to:

 

(a)          make and keep public information regarding the Company available, as those terms are understood and defined in Rule 144
under the Securities Act (or any similar provision then in effect), at all times from and after the date hereof;

 

(b)          file with the Commission in a timely manner all reports and other documents required of the Company under the Securities
Act and the Exchange Act at all times from and after the date hereof; and

 

(c)          so long as a Holder owns any Registrable Securities, furnish (i) to the extent accurate, forthwith upon request, a written
statement of the Company that it has complied with the reporting requirements of Rule 144 under the Securities Act (or any similar
provision then in effect) and (ii) unless otherwise available via the Commission’s EDGAR filing system, to such Holder forthwith
upon request a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed
as such Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing such Holder to sell
any Registrable Securities without registration.

 

Section 2.10       
Transfer or Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities
under this Article II may be transferred or assigned by each Holder to one or more transferees or assignees of Registrable
Securities; provided, however, that (a) unless any such transferee or assignee is an Affiliate of, and after such
transfer or assignment continues to be an Affiliate of, such Holder, the amount of Registrable Securities transferred or assigned
to such transferee or assignee shall represent at least $15 million of Registrable Securities, calculated on the basis of the
Issue Price or such lesser amount if it constitutes the remaining holdings of the Holder and its Affiliates, (b) the Company is
given written notice prior to any said transfer or assignment, stating the name and address of each such transferee or assignee
and identifying the securities with respect to which such registration rights are being transferred or assigned and (c) each such
transferee or assignee assumes in writing responsibility for its portion of the obligations of such transferring Holder under
this Agreement.

 

Section 2.11       
Limitation on Subsequent Registration Rights. From and after the date hereof, the Company shall not, without the
prior written consent of the Holders of at least the Registrable Securities Required Voting Percentage, enter into any agreement
with any current or future holder of any securities of the Company that would allow such current or future holder to require the
Company to include securities in any registration statement filed by the Company for Other Holders on a basis other than pari
passu with or expressly subordinate to the piggyback rights of the Holders of Registrable Securities hereunder; provided,
that in no event shall the Company enter into any agreement that would permit another holder of securities of the Company to participate
on a superior or pari passu basis (in terms of priority of cut-back based on advice of Underwriters) with a Holder requesting
registration or takedown in an Underwritten Offering pursuant to Section 2.03(a).

 

     

     

    

 

Section 2.12       
Sale Restrictions. Each Holder agrees not to publicly or privately sell, dispose of or distribute any shares of
Company Common Stock (including any shares of Company Common Stock issuable upon the conversion of any derivative securities)
that are beneficially owned by such Holder, or issue (publicly or privately) any derivative securities whose value is based on
shares of Company Common Stock, until after the date that is six (6) months after the date hereof. For the avoidance of doubt,
notwithstanding anything to the contrary contained in this Agreement or the Purchase Agreement, no Holder shall have the right
to publicly or privately sell, dispose of or distribute any shares of Company Common Stock (including any shares of Company Common
Stock issuable upon the conversion of any derivative securities), or issue (publicly or privately) any derivative securities whose
value is based on shares of Company Common Stock, prior to the date that is six (6) months after the date hereof.

 

Article
III.

MISCELLANEOUS

 

Section 3.01       
Communications. All notices, demands and other communications provided for hereunder shall be in writing and shall
be given by registered or certified mail, return receipt requested, telecopy, air courier guaranteeing overnight delivery, personal
delivery or (in the case of any notice given by the Company to JDH) email to the following addresses:

 

(a)          If to JDH:

 

JDH Capital Holdings, L.P.

1111 Travis Street

Houston, Texas 77208-1229

		Attention:	Ryan Connelly

		Email:	rconnelly@hilcorp.com

 

with copies to (which shall not constitute notice):

 

Kirkland & Ellis LLP

609 Main Street

45th Floor

Houston, Texas 77002

		Attention:	William W. Bos, P.C.

			Jhett R. Nelson

		Email:	william.bos@kirkland.com

		 	jhett.nelson@kirkland.com

 

(b)          If to the Company:

 

Archrock, Inc.

9807 Katy Freeway, Suite 100

Houston, Texas 77024

		Attention:	Stephanie C. Hildebrandt

		Email:	Stephanie.Hildebrandt@archrock.com

 

with copies to (which shall not constitute notice):

 

Latham & Watkins LLP

811 Main Street, Suite 3700

Houston TX 77002

		Attention:	Ryan J. Maierson

			Nick S. Dhesi

		Email:	ryan.maierson@lw.com

		 	nick.dhesi@lw.com

 

     

     

    

 

or to such other address as the Company
or JDH may designate to each other in writing from time to time or, if to a transferee or assignee of JDH or any transferee or
assignee thereof, to such transferee or assignee at the address provided pursuant to Section 2.10. All notices and communications
shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; upon actual receipt if sent by
certified or registered mail, return receipt requested, or regular mail, if mailed; upon actual receipt of the facsimile or email
copy, if sent via facsimile or email; and upon actual receipt when delivered to an air courier guaranteeing overnight delivery.

 

Section 3.02       
Binding Effect. This Agreement shall be binding upon the Company, each of the Holders and their respective successors
and permitted assigns, including binding upon (i) in the case of the Company, any Person that will be a successor to the Company,
whether by merger, consolidation, reorganization, charter amendment, sale of all or substantially all assets or otherwise and
(ii) in the case of JDH, subsequent Holders of Registrable Securities to the extent permitted herein. Except as expressly provided
in this Agreement, this Agreement shall not be construed so as to confer any right or benefit upon any Person other than the parties
to this Agreement and their respective successors and permitted assigns.

 

Section 3.03       
Assignment of Rights. Except as provided in Section 2.10 and as contemplated by Section 3.02, neither
this Agreement nor any of the rights, benefits or obligations hereunder may be assigned or transferred, by operation of law or
otherwise, by any party hereto without the prior written consent of the other party.

 

Section 3.04       
Recapitalization, Exchanges, Etc. Affecting Shares of Company Common Stock. The provisions of this Agreement shall
apply to the full extent set forth herein with respect to any and all shares of common stock of the Company or any successor or
assign of the Company (whether by merger, acquisition, consolidation, reorganization, sale of assets or otherwise) that may be
issued in respect of, in exchange for or in substitution of, the Registrable Securities, and shall be appropriately adjusted for
combinations, unit splits, recapitalizations, pro rata distributions of shares and the like occurring after the date of this Agreement.
As a condition to the effectiveness of any transaction discussed in the prior sentence, the Company shall make provision to ensure
that any successor or assign of the Company (i) acknowledges, adopts and assumes in full the Company’s obligations pursuant
to this Agreement or (ii) enters into a new registration rights agreement with the holders of the Registrable Securities providing
for the same rights set forth herein.

 

Section 3.05       
Aggregation of Registrable Securities. All Registrable Securities held or acquired by Persons who are Affiliates
of one another shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

 

Section 3.06       
Specific Performance. Damages in the event of breach of this Agreement by a party hereto may be difficult, if not
impossible, to ascertain, and it is therefore agreed that each such Person, in addition to and without limiting any other remedy
or right it may have, will have the right to seek an injunction or other equitable relief in any court of competent jurisdiction,
enjoining any such breach, and enforcing specifically the terms and provisions hereof, and each of the parties hereto hereby waives
any and all defenses it may have on the ground of lack of jurisdiction or competence of the court to grant such an injunction
or other equitable relief. The existence of this right will not preclude any such Person from pursuing any other rights and remedies
at law or in equity that such Person may have.

 

     

     

    

 

Section 3.07       
Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in separate
counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original and all of which counterparts,
taken together, shall constitute but one and the same agreement.

 

Section 3.08       
Governing Law, Submission to Jurisdiction. This Agreement, and all claims or causes of action (whether in contract
or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this
Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made
in or in connection with this Agreement), will be construed in accordance with and governed by the laws of the State of Delaware
without regard to principles of conflicts of laws. Any action against any party relating to the foregoing shall be brought in
any federal or state court of competent jurisdiction located within the State of Delaware, and the parties hereto hereby irrevocably
submit to the exclusive jurisdiction of any federal or state court located within the State of Delaware over any such action.
The parties hereby irrevocably waive, to the fullest extent permitted by applicable law, any objection which they may now or hereafter
have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum for the maintenance
of such dispute. Each of the parties hereto agrees that a judgment in any such dispute may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by law.

 

Section 3.09       
Waiver of Jury Trial. THE PARTIES TO THIS AGREEMENT EACH HEREBY WAIVE, AND AGREE TO CAUSE THEIR AFFILIATES TO WAIVE,
TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING
UNDER THIS AGREEMENT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT
OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER
IN CONTRACT, TORT, EQUITY OR OTHERWISE. THE PARTIES TO THIS AGREEMENT EACH HEREBY AGREE AND CONSENT THAT ANY SUCH CLAIM, DEMAND,
ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL
COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER
OF THEIR RIGHT TO TRIAL BY JURY.

 

Section 3.10       
Entire Agreement. This Agreement, the Purchase Agreement and the other agreements and documents referred to herein
and therein are intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement
of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein. There
are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein or in the Purchase
Agreement with respect to the rights granted by the Company or any of its Affiliates or JDH or any of its Affiliates set forth
herein or therein. This Agreement, the Purchase Agreement and the other agreements and documents referred to herein or therein
supersede all prior agreements and understandings between the parties with respect to such subject matter.

 

     

     

    

 

Section 3.11       
Amendment. This Agreement may be amended only by means of a written amendment signed by the Company and the Holders
of at least the Registrable Securities Required Voting Percentage; provided, however, that no such amendment shall
adversely affect the rights of any Holder hereunder without the consent of such Holder. Any amendment, supplement or modification
of or to any provision of this Agreement, any waiver of any provision of this Agreement, and any consent to any departure by the
Company or any Holder from the terms of any provision of this Agreement shall be effective only in the specific instance and for
the specific purpose for which such amendment, supplement, modification, waiver or consent has been made or given.

 

Section 3.12       
No Presumption. This Agreement has been reviewed and negotiated by sophisticated parties with access to legal counsel
and shall not be construed against the drafter.

 

Section 3.13       
Obligations Limited to Parties to Agreement. Each of the parties hereto covenants, agrees and acknowledges that,
other than as set forth herein, no Person other than JDH, the Holders, their respective permitted assignees and the Company shall
have any obligation hereunder and that, notwithstanding that one or more of such Persons may be a corporation, partnership or
limited liability company, no recourse under this Agreement or under any documents or instruments delivered in connection herewith
shall be had against any former, current or future director, officer, employee, agent, general or limited partner, manager, member,
stockholder or Affiliate of any of such Persons or their respective permitted assignees, or any former, current or future director,
officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of any of the foregoing, whether
by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any applicable law, it being expressly
agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any former,
current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of
any of such Persons or any of their respective assignees, or any former, current or future director, officer, employee, agent,
general or limited partner, manager, member, stockholder or Affiliate of any of the foregoing, as such, for any obligations of
such Persons or their respective permitted assignees under this Agreement or any documents or instruments delivered in connection
herewith or for any claim based on, in respect of or by reason of such obligation or its creation, except, in each case, for any
assignee of JDH or a Selling Holder hereunder.

 

     

     

    

 

Section 3.14       
Interpretation. Article, Section and Schedule references in this Agreement are references to the corresponding Article,
Section or Schedule to this Agreement, unless otherwise specified. All Schedules to this Agreement
are hereby incorporated and made a part hereof as if set forth in full herein and are an integral part of this Agreement. All
references to instruments, documents, contracts and agreements are references to such instruments, documents, contracts and agreements
as the same may be amended, supplemented and otherwise modified from time to time, unless otherwise specified. The word “including”
shall mean “including but not limited to” and shall not be construed to limit any general statement that it follows
to the specific or similar items or matters immediately following it. Whenever the Company has an obligation under this Agreement,
the expense of complying with that obligation shall be an expense of the Company unless otherwise specified. Any reference in
this Agreement to “$” shall mean U.S. dollars. Whenever any determination, consent or approval is to be made or given
by JDH, such action shall be in such Holder’s sole discretion, unless otherwise specified in this Agreement. If any provision
in this Agreement is held to be illegal, invalid, not binding or unenforceable, (a) such provision shall be fully severable and
this Agreement shall be construed and enforced as if such illegal, invalid, not binding or unenforceable provision had never comprised
a part of this Agreement, and the remaining provisions shall remain in full force and effect, and (b) the parties hereto shall
negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in
an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest
extent possible. When calculating the period of time before which, within which or following which any act is to be done or step
taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded. If the last
day of such period is not a Business Day, the period in question shall end on the next succeeding Business Day. Any words imparting
the singular number only shall include the plural and vice versa. The words such as “herein,” “hereinafter,”
“hereof” and “hereunder” refer to this Agreement as a whole and not merely to a subdivision in which such
words appear unless the context otherwise requires. The provision of a Table of Contents, the division of this Agreement into
Articles, Sections and other subdivisions and the insertion of headings are for convenience of reference only and shall not affect
or be utilized in construing or interpreting this Agreement.

 

[Signature Pages Follow.]

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto execute this Agreement, effective as of the date first above written.

 

	 	ARCHROCK, INC.
	 	 	 
	 	By:	/s/ D. Bradley Childers
	 	Name:	D. Bradley Childers
	 	Title:	President and Chief Executive Officer
	 	 	 
	 	 	 
	 	JDH CAPITAL HOLDINGS, L.P.
	 	 	 
	 	By: JDH Capital Company, its general partner
	 	 	 
	 	By:	/s/ Ryan Connelly
	 	Name:  	Ryan Connelly
	 	Title:	Managing Director

 

[Signature Page to Registration Rights
Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]